Assignee
SPECTRUM PHARMACEUTICALS INC
US·27 granted patents·25 pending applications·163 citations·filing 2001–2025
Top patents by PatentIndex Score
52 records- 0192US8026216B2Methods and compositions for contributing to the treatment of cancersSPECTRUM PHARMACEUTICALS INC·Filed 2008·Granted Sep 27, 2011·8 cites·11 claims
- 0291US10350240B2Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and useSPECTRUM PHARMACEUTICALS INC·Filed 2013·Granted Jul 16, 2019·27 cites·20 claims
- 0390US8349802B2Methods and compositions for contributing to the treatment of cancersSPECTRUM PHARMACEUTICALS INC·Filed 2011·Granted Jan 8, 2013·6 cites·11 claims
- 0490US6894071B2Medical compositions for intravesical treatment of bladder cancerSPECTRUM PHARMACEUTICALS INC·Filed 2002·Granted May 17, 2005·42 cites·10 claims
- 0589US6770638B2Tetrahydroindolone and purine derivatives linked to arylpiperazinesSPECTRUM PHARMACEUTICALS INC·Filed 2002·Granted Aug 3, 2004·22 cites·12 claims
- 0687US8030278B2Methods, compositions and articles of manufacture for contributing to the treatment of cancersSPECTRUM PHARMACEUTICALS INC·Filed 2009·Granted Oct 4, 2011·7 cites·16 claims
- 0786US6759427B2Synthesis and methods of use of tetrahydroindolone analogues and derivativesSPECTRUM PHARMACEUTICALS INC·Filed 2001·Granted Jul 6, 2004·16 cites·2 claims
- 0885US6982269B2Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivativesSPECTRUM PHARMACEUTICALS INC·Filed 2002·Granted Jan 3, 2006·16 cites·17 claims
- 0983US11267858B2Methods of treatment using G-CSF protein complexSPECTRUM PHARMACEUTICALS INC·Filed 2019·Granted Mar 8, 2022·2 cites·21 claims
- 1083US7977369B2Medical compositions for intravesical treatment of bladder cancerSPECTRUM PHARMACEUTICALS INC·Filed 2008·Granted Jul 12, 2011·6 cites·14 claims
- 1182US9308235B2Treatment of primary and metastatic carcinomaSPECTRUM PHARMACEUTICALS INC·Filed 2013·Granted Apr 12, 2016·3 cites·17 claims
- 1281US12350315B2Methods of treating neutorpenia using G-CSF protein complexSPECTRUM PHARMACEUTICALS INC·Filed 2023·Granted Jul 8, 2025·0 cites·13 claims
- 1381US8377456B2Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivativesSPECTRUM PHARMACEUTICALS INC·Filed 2011·Granted Feb 19, 2013·3 cites·26 claims
- 1481US2026000733A1Novel methods of treating neutorpenia using g-csf protein complexSPECTRUM PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1580US12318430B2Methods of treating neutorpenia using G-CSF protein complexSPECTRUM PHARMACEUTICALS INC·Filed 2023·Granted Jun 3, 2025·0 cites·15 claims
- 1679US2025197466A1Methods of treatment using g-csf protein complexSPECTRUM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1778US9295666B2Bladder cancer treatment and methodsSPECTRUM PHARMACEUTICALS INC·Filed 2013·Granted Mar 29, 2016·1 cites·12 claims
- 1878US8852543B2Rare earth metal compounds, methods of making, and methods of using the sameSPECTRUM PHARMACEUTICALS INC·Filed 2014·Granted Oct 7, 2014·2 cites·7 claims
- 1977US2025367257A1Methods of treating neutorpenia using g-csf protein complexSPECTRUM PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2075US11439643B2Combination therapy using belinostat and pralatrexate to treat lymphomaSPECTRUM PHARMACEUTICALS INC·Filed 2016·Granted Sep 13, 2022·1 cites·5 claims
- 2174US12202871B2Methods of treatment using G-CSF protein complexSPECTRUM PHARMACEUTICALS INC·Filed 2022·Granted Jan 21, 2025·0 cites·20 claims
- 2273US8734818B2Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivativesSPECTRUM PHARMACEUTICALS INC·Filed 2013·Granted May 27, 2014·1 cites·26 claims
- 2371US2023106731A1Inhibitors of mutant family tyrosine-kinasesSPECTRUM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2468US11684655B2Methods of treating neutorpenia using G-CSF protein complexSPECTRUM PHARMACEUTICALS INC·Filed 2020·Granted Jun 27, 2023·0 cites·22 claims
- 2568US2025121032A1Methods of treating chemotherapy induced neutropenia using fixed doses of g-csf protein complexSPECTRUM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2664US2009076123A1Medical Compositions for Intravesical Treatment of Bladder CancerSPECTRUM PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2763US2014288143A1Bladder cancer treatment and methodsSPECTRUM PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2863US2015004086A1Rare earth metal compounds, methods of making, and methods of using the sameSPECTRUM PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2961US12171804B2Methods of treating chemotherapy induced neutropenia using fixed doses of eflapegrastimSPECTRUM PHARMACEUTICALS INC·Filed 2021·Granted Dec 24, 2024·0 cites·9 claims
- 3061US2010119602A1Phosphate binder with reduced pill burdenSPECTRUM PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 3160US11541012B1Compositions comprising disodium levofolinateSPECTRUM PHARMACEUTICALS INC·Filed 2019·Granted Jan 3, 2023·0 cites·15 claims
- 3260US2018280468A1Treatment of primary and metastatic carcinomaSPECTRUM PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3358US10022421B2Treatment of primary and metastatic carcinomaSPECTRUM PHARMACEUTICALS INC·Filed 2016·Granted Jul 17, 2018·0 cites·11 claims
- 3458US9511091B2Rare earth metal compounds, methods of making, and methods of using the sameSPECTRUM PHARMACEUTICALS INC·Filed 2015·Granted Dec 6, 2016·0 cites·11 claims
- 3558US2020261455A1Inhibitors of mutant family tyrosine-kinasesSPECTRUM PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3658US2007010570A1Medical Compositions for Intravesical Treatment of Bladder CancerSPECTRUM PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 3757US2011123628A1Rare earth metal compounds, methods of making, and methods of using the sameSPECTRUM PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 3856US9713616B2Pharmaceutical compositions comprising L-leucovorinSPECTRUM PHARMACEUTICALS INC·Filed 2013·Granted Jul 25, 2017·0 cites·13 claims
- 3955US2010278910A1Rare earth metal compounds, methods of making, and methods of using the sameSPECTRUM PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 4055US2005215615A1Medical compositions for intravesical treatment of bladder cancerSPECTRUM PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 4154US2021353627A1Novel quinazoline egfr inhibitorsSPECTRUM PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 4254US2006063788A1Carbon monoxide dependent guanylyl cyclase modifiers and methods of useSPECTRUM PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 4353US2022296598A1Poziotinib Combination with VEGFR2 Inhibitors and Methods of Use ThereofSPECTRUM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4453US2021145834A1Combination of poziotinib with cytotoxic agent and/or other molecularly targeted agent and use thereofSPECTRUM PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 4551US2011251143A1Stable elsamitrucin salt formulationsSPECTRUM PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 4651US2014336268A1Formulations of vitamin k analogs for topical useSPECTRUM PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4751US2023027238A1Methods of treatment using g-csf protein complexSPECTRUM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4850US2023277628A1Methods for promoting anti-tumor immune response in a subject in need thereof using encapsulated interleukin 12SPECTRUM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 4946US2021260064A1Poziotinib combinations with an anti-her1, her2 or her4 antibody and methods of use thereofSPECTRUM PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 5044US2007293445A1Stable Elsamitrucin Salts Suitable for Pharmaceutical FormulationsSPECTRUM PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when SPECTRUM PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →